Dr. Sabine Hazan is the president and founder of ProgenaBiome, a genetic sequencing research laboratory, and a medical doctor specializing in gastroenterology, and an expert on the intestinal microbiome. She provides compelling testimony on her experience with clinical trials during the pandemic, but most significantly how she discovered through clinical trials that the COVID virus was susceptible to any patient with a strong microbiome, and strong gut health, specifically those with bifidobacteria which is in the realm of probiotics.
* The above video is being streamed via Odysee. Check back often as we continue to update the complete list of links to all witness testimonies in both video and audio/podcast formats.
Transcript text
Summary
Dr. Sabine Hazan is the president and founder of ProgenaBiome, a genetic sequencing research laboratory, and a medical doctor specializing in gastroenterology, and an expert on the intestinal microbiome. She provides compelling testimony on her experience with clinical trials during the pandemic, but most significantly how she discovered through clinical trials that the COVID virus was susceptible to any patient with a strong microbiome, and strong gut health, specifically those with bifidobacteria which is in the realm of probiotics. She further discusses her past studies where findings showed that patients suffering from lyme disease, Crohn’s disease and cancer had no bifidobacteria in their microbiome. During her COVID clinical trials she also learned that those who had taken the COVID-19 mRNA vaccines also lost their bifidobacteria within a few months of receiving the injection.
She discusses how there were many agencies and other outside sources that were interfering her her research, and how the adherence to scientific method has not been all but lost in the current climate.
Suivre la CeNC sur nos chaînes de médias sociaux et nos podcasts:
